Jennifer Mansion is suing Eli Lilly and Co. for retaliation in employment in violation of the False Claims Act, Texas Medicaid Fraud Prevention Act, Texas public policy, and national origin…

In a recent court filing in the United States District Court for the District of New Jersey, Jennifer Mansion has filed a lawsuit against pharmaceutical giant Eli Lilly and Co. The complaint, lodged on November 7, 2025, alleges retaliation under the False Claims Act and Texas Medicaid Fraud Prevention Act, as well as national origin discrimination and retaliation under 42 U.S.C. § 1981. Mansion claims she was terminated from her role as a Senior Territory Manager after raising concerns about off-label promotion of the drug Mounjaro for weight loss, which is not FDA-approved for such use. The suit seeks damages for lost wages, benefits, and other compensatory damages.

Source: 325cv17282_Mansion_v_Eli_Lilly_and_Co_Complaint_District_New_Jersey.pdf